The global Platelet Rich Plasma (PRP) Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.
Market Overview:
Global Platelet Rich Plasma (PRP) Market is estimated to reach USD 647.01 million by 2025 owing to the growing prevalence of orthopedic disorders like knee osteoarthritis, achilles tendinopathy, rotator cuff tears and increasing application of platelet rich plasma in cosmetic surgery. Platelet rich plasma is a common treatment at present in the cosmetic (dermatological) field. It stimulates fibroblasts in the skin and makes them produce collagen fibers since (PRP) Platelet Rich Plasma is made from the patient’s body, the treatment is considered very safe.
Key Players:
- T-Biotechnology
- Arthrex
- Terumo BCT, Inc.
- EmCyte Corporation
- DePuy Synthes
- Zimmer Biomet
- Stryker
- Glofinn OY
- PRP America
Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/platelet-rich-plasma-prp-market/request-sample
Growth Drivers:
Platelet rich plasma therapy has gained traction due to its wide application with no side-effects. It is also used for treating injured tendons, joints, muscles, and ligaments. PRP therapy also reduces patients’ low back pain and help them recover soon. It is also extensively used in cases of baldness that increases the blood flow and supports in hair growth.
Since, the patient prefer minimally invasive surgeries, the cost of technological use is high. On the other hand, speedy and efficient healing post a surgery remains therapeutic-stage of great importance for the caretakers and PRP has been serving the cause effectively. The prevalence of orthopedic disorders that require surgery, continue to grow along with the trend of cosmetic surgeries in developed regions with a vast geriatric population.
Platelet Rich Plasma industry is predicted to attain new heights across geographies. Leukocyte rich PRP has witnessed higher growth since it stimulates the growth of tissues that help in the treatment of soft tissue flaws of human body. The major driving factors of the market are the growing elderly population, increase in occurrence of sports and orthopedic injuries, the increasing number of cosmetic surgeries, technological advancements and rise in awareness regarding PRP therapies.
However, low quality control of test results restrain the platelet rich plasma market growth. Also the high cost of platelet rich plasma processing kit with lower effectiveness hinders the market. If PRP therapy tends to be economic, the treatment turns out to gain prominence and certainly helps the researchers to conduct several experiments. Moreover, even though the therapy is considered as useful, a few scientific evidences are hampering the growth of the industry.
Product Outlook:
- Pure PRP
- Leukocyte-Rich PRP
- Leukocyte-Rich Fibrin
Application Outlook:
- Orthopedics
- Cosmetic Surgery & Dermatology
- Ophthalmic Surgery
- Neurosurgery
- General surgery
Regional Outlook:
Geographically, platelet rich plasma (PRP) industry is segmented as North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America is projected to hold larger share of the market in coming years due to the high prevalence of orthopedic disorders and sports injuries. Europe is also expected to dominate platelet rich plasma market due to the rising demand for cosmetic surgeries in the forecast period.
Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/
No comments:
Post a Comment